Zynerba Pharmaceuticals to Present at Two Upcoming Virtual Investor Conferences
DEVON, Pa., Sept. 10, 2020 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies […]